Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.08.2020 | Case report

Ledipasvir/sofosbuvir

Diffuse large B-cell lymphoma: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Sakai H, et al. Development of diffuse large b-cell lymphoma after sofosbuvir-ledipasvir treatment for chronihepatitis c: A case report and literature review. Molecular and Clinical Oncology 13: 1-6, No. 3, Sep 2020. Available from: URL: http://doi.org/10.3892/mco.2020.2071 Sakai H, et al. Development of diffuse large b-cell lymphoma after sofosbuvir-ledipasvir treatment for chronihepatitis c: A case report and literature review. Molecular and Clinical Oncology 13: 1-6, No. 3, Sep 2020. Available from: URL: http://​doi.​org/​10.​3892/​mco.​2020.​2071
Metadaten
Titel
Ledipasvir/sofosbuvir
Diffuse large B-cell lymphoma: case report
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-82149-9

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Antineoplastics

Case report

Antituberculars

Case report

Antineoplastics

Case report

Cyclophosphamide